VITAMIN D STATUS AND EFFECTS OF 25-HYDROXYVITAMIN D (25OHD) SERUM LEVELS ON THE RISK OF FRACTURES IN THE TERIPARATIDE VS. RISEDRONATE: VERO CLINICAL TRIAL

S Minisola; F Marin; D Kendler; P Geusens; C Zerbini; L Russo; S Greenspan; E Casado; Astrid Fahrleitner-Pammer; J Stepan; E Lespessailles; R Moericke; A Bagur; P Lakatos; P Lopez Romero; JJ Body

VITAMIN D STATUS AND EFFECTS OF 25-HYDROXYVITAMIN D (25OHD) SERUM LEVELS ON THE RISK OF FRACTURES IN THE TERIPARATIDE VS. RISEDRONATE: VERO CLINICAL TRIAL

S Minisola
, F Marin
, D Kendler
, P Geusens
, C Zerbini
, L Russo
, S Greenspan
, E Casado
, Astrid Fahrleitner-Pammer
, J Stepan
, E Lespessailles
, R Moericke
, A Bagur
, P Lakatos
, P Lopez Romero
, JJ Body

Division of Endocrinology and Diabetology

Research output: Contribution to journal › Conference abstract

Original language	English
Journal	Osteoporosis International
Publication status	Published - 2018
Event	World Congress on Osteoporosis, Osteoarthritis and Musculosekeletal Diseases 2018 - Krakow, Poland Duration: 19 Apr 2018 → 22 Apr 2018

Branches of science

302 Clinical Medicine

Links

Web of Science

VITAMIN D STATUS AND EFFECTS OF 25-HYDROXYVITAMIN D (25OHD) SERUM LEVELS ON THE RISK OF FRACTURES IN THE TERIPARATIDE VS. RISEDRONATE: VERO CLINICAL TRIAL
Minisola, S. (Author), Marin, F. (Author), Kendler, D. (Author), Geusens, P. (Author), Zerbini, C. (Author), Russo, L. (Author), Greenspan, S. (Author), Casado, E. (Author), Fahrleitner-Pammer, A. (Author), Stepan, J. (Author), Lespessailles, E. (Author), Moericke, R. (Author), Bagur, A. (Author), Lakatos, P. (Author), Lopez Romero, P. (Author) & Body, J. (Author)
2018
Activity: Talk, presentation or poster › Scientific talk or presentation › On site

Cite this

Minisola, S., Marin, F., Kendler, D., Geusens, P., Zerbini, C., Russo, L., Greenspan, S., Casado, E., Fahrleitner-Pammer, A., Stepan, J., Lespessailles, E., Moericke, R., Bagur, A., Lakatos, P., Lopez Romero, P., & Body, JJ. (2018). VITAMIN D STATUS AND EFFECTS OF 25-HYDROXYVITAMIN D (25OHD) SERUM LEVELS ON THE RISK OF FRACTURES IN THE TERIPARATIDE VS. RISEDRONATE: VERO CLINICAL TRIAL. Osteoporosis International.

@article{42c6440e790e43feb3d8f2c4b3238423,

title = "VITAMIN D STATUS AND EFFECTS OF 25-HYDROXYVITAMIN D (25OHD) SERUM LEVELS ON THE RISK OF FRACTURES IN THE TERIPARATIDE VS. RISEDRONATE: VERO CLINICAL TRIAL",

author = "S Minisola and F Marin and D Kendler and P Geusens and C Zerbini and L Russo and S Greenspan and E Casado and Astrid Fahrleitner-Pammer and J Stepan and E Lespessailles and R Moericke and A Bagur and P Lakatos and \{Lopez Romero\}, P and JJ Body",

year = "2018",

language = "English",

journal = "Osteoporosis International",

issn = "0937-941X",

publisher = "Springer Science and Business Media Deutschland GmbH",

note = "World Congress on Osteoporosis, Osteoarthritis and Musculosekeletal Diseases 2018, WCO IOF ESCEO 2018 ; Conference date: 19-04-2018 Through 22-04-2018",

}

Minisola, S, Marin, F, Kendler, D, Geusens, P, Zerbini, C, Russo, L, Greenspan, S, Casado, E, Fahrleitner-Pammer, A, Stepan, J, Lespessailles, E, Moericke, R, Bagur, A, Lakatos, P, Lopez Romero, P & Body, JJ 2018, 'VITAMIN D STATUS AND EFFECTS OF 25-HYDROXYVITAMIN D (25OHD) SERUM LEVELS ON THE RISK OF FRACTURES IN THE TERIPARATIDE VS. RISEDRONATE: VERO CLINICAL TRIAL', Osteoporosis International.

TY - JOUR

T1 - VITAMIN D STATUS AND EFFECTS OF 25-HYDROXYVITAMIN D (25OHD) SERUM LEVELS ON THE RISK OF FRACTURES IN THE TERIPARATIDE VS. RISEDRONATE: VERO CLINICAL TRIAL

AU - Minisola, S

AU - Marin, F

AU - Kendler, D

AU - Geusens, P

AU - Zerbini, C

AU - Russo, L

AU - Greenspan, S

AU - Casado, E

AU - Fahrleitner-Pammer, Astrid

AU - Stepan, J

AU - Lespessailles, E

AU - Moericke, R

AU - Bagur, A

AU - Lakatos, P

AU - Lopez Romero, P

AU - Body, JJ

PY - 2018

Y1 - 2018

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000440102402026

M3 - Conference abstract

SN - 0937-941X

JO - Osteoporosis International

JF - Osteoporosis International

T2 - World Congress on Osteoporosis, Osteoarthritis and Musculosekeletal Diseases 2018

Y2 - 19 April 2018 through 22 April 2018

ER -

VITAMIN D STATUS AND EFFECTS OF 25-HYDROXYVITAMIN D (25OHD) SERUM LEVELS ON THE RISK OF FRACTURES IN THE TERIPARATIDE VS. RISEDRONATE: VERO CLINICAL TRIAL

Branches of science

Links

Activities

VITAMIN D STATUS AND EFFECTS OF 25-HYDROXYVITAMIN D (25OHD) SERUM LEVELS ON THE RISK OF FRACTURES IN THE TERIPARATIDE VS. RISEDRONATE: VERO CLINICAL TRIAL

Cite this